Current experience with 5-HT3 receptor antagonists in fibromyalgia.
about
Specific treatment of residual fatigue in depressed patients.The art of prescribing. Depression and fibromyalgia syndrome (FMS): pharmacologic considerations.Efficacy and tolerability of intravenous tropisetron in the treatment of fibromyalgia.Implications of palonosetron in elderly patients undergoing laparoscopic cholecystectomy with respect to its anti-shivering effect.
P2860
Current experience with 5-HT3 receptor antagonists in fibromyalgia.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Current experience with 5-HT3 receptor antagonists in fibromyalgia.
@ast
Current experience with 5-HT3 receptor antagonists in fibromyalgia.
@en
Current experience with 5-HT3 receptor antagonists in fibromyalgia.
@nl
type
label
Current experience with 5-HT3 receptor antagonists in fibromyalgia.
@ast
Current experience with 5-HT3 receptor antagonists in fibromyalgia.
@en
Current experience with 5-HT3 receptor antagonists in fibromyalgia.
@nl
prefLabel
Current experience with 5-HT3 receptor antagonists in fibromyalgia.
@ast
Current experience with 5-HT3 receptor antagonists in fibromyalgia.
@en
Current experience with 5-HT3 receptor antagonists in fibromyalgia.
@nl
P1476
Current experience with 5-HT3 receptor antagonists in fibromyalgia.
@en
P2093
Michael Späth
P304
P356
10.1016/S0889-857X(01)00014-X
P577
2002-05-01T00:00:00Z